Alendronate Sodium Tablets
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D2-25-R-0023 | Alendronate Sodium Tablets | |
| Synopsis | ||
|
Amendment 0001 has been issued to extend the solicitation closing date to November 3, 2025. All other terms and conditions of the solicitation remain unchanged. .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D2-25-R-0023 | Alendronate Sodium Tablets | |
| Synopsis | ||
|
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Alendronate Sodium Tablets. Procurement details follow. Alendronate Sodium: 35 MG Tablets in 4 count boxes and 70 MG Tablets in 4 count boxes. (1 card of 4 blister tablets per box). This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | Presolicitation | |
